Are you OPEN to CLOSE your bioprocess?

by Amandine Biehler | October 24, 2023

Bioprocessing operators in a closed processing CNC space

Join our webinar – The Closed Processing Advantage: Optimizing Biopharma Facilities – as we explore the transformative journey towards the facility of the future!

The rise of novel modalities, multi-product manufacturing, and the demand for more flexible facilities will drive an increased adoption of closed processing technologies over the next several years. Learn how closed processing can help reduce contamination and safety risks, decrease costly environmental control measures, and maximize facility utilization.

Benefits gained from using single-use, closed processing solutions extend well beyond financial and time savings, ultimately contributing to overarching industry goals.

Make sure to attend our October 31st webinar to learn more on how closed, connected, and continuous-enabled processes can help biomanufacturers to:

  • Minimize contamination risks
  • Reduce costs
  • Accelerate time to market, and
  • Optimize facility utilization

Watch the on demand webinar to learn industry guidance and best practices for the adoption of closed processing!

Related Posts

Vaccine Maker’s Toolkit: Strategies For Manufacturing And Supply Management

This collection of insights, produced through a partnership between

Merck KGaA, Darmstadt, Germany
,[geot_filter region="north-america" country=""...

Coming Full Circle with Biopharma Recycling

This post discusses the environmental challenges posed by the Biopharmaceutical industry's heavy reliance on single-use systems and the...


In this webinar, join industry experts to learn about strategies to accelerate mRNA therapies and enable scalability and...

Improved endotoxin removal using ecofriendly detergents for intensified plasmid capture

Purification efficiency evaluated endotoxin and host cell protein (HCP) clearance, plasmid yield, potential interference of the detergents with...

Mirrored disco balls

Bridging the Sponsor – CMO Data Gulf

Single-source manufacture of biopharmaceuticals is becoming more and more rare. Increasingly, biomanufacturers or “sponsor” companies partner with contract…

Biopharma’s evolution: learnings from the pandemic for a revived regulatory landscape

The covid-19 pandemic forced rapid vaccine development and market approval, shortening a process that normally takes years to...

Scroll to Top